Clinical Trial Update: Efficacy Study of Lucentis in the Treatment of Retinoblastoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 efficacy study evaluating ranibizumab (Lucentis) for treating retinoblastoma. The update does not provide results and the status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Retinoblastoma | Phase 2 | Status: UNKNOWN